• Contact/
  • Home/

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • Advent Life Sciences
  • Advent Life Sciences

Page 21 of 25

 
<< Start < Prev 16 17 18 19 20 21 22 23 24 25Next >End >>
30.03.2010The Leukemia & Lymphoma Society and Avila Therapeutics Enter Partnership to Accelerate Development of AVL-292 For Patients with Cell B Malignancies

Press Release

22.03.2010Impressive report issued by Soleil Securities on Advent portfolio company Cellnovo

In The News

16.03.20104-Antibody announces long-term collaboration with Boehringer Ingelheim with a maximum value of EUR 177.5m (CHF 266m) for 4-Antibody

Press Release

10.02.2010Biocartis acquires Philips Technology Platform for Automated DNA/RNA Molecular Diagnostic Testing

Press Release

19.01.2010AMT submits its lead product Glybera® Application for Marketing Authorisation Application to EMA

Press Release

24.11.2009Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds

Press Release

03.11.2009Avila presents data on its novel, orally-available protease inhibitor, AVL-181, demonstrating viral clearance of hepatitis C virus in preclinical models

Press Release

02.11.2009Micromet and Sanofi-aventis Sign Global Collaboration and License Agreement for New Solid Tumor BiTE Antibody

Press Release

20.10.2009Privately held CardiacAssist reports record revenues for nine-month financial results

Press Release

15.10.2009Biocartis raises €10 million in Series A financing round

Press Release



  • Privacy Policy
  • Legal and Regulatory Matters

©2022 Advent Life Sciences